Gene · 8451
Papers1,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma. | NPJ Precis Oncol | 2022 | 35233069 | PubTator, text mining | PubMed |
| XPG: a multitasking genome caretaker. | Cell Mol Life Sci | 2022 | 35230528 | PubTator, text mining | PubMed |
| A Comprehensive Review of Biological Roles and Interactions of Cullin-5 Protein. | ACS Omega | 2022 | 35224323 | PubTator, text mining | PubMed |
| The paradoxical functions of long noncoding RNAs in hepatocellular carcinoma: Implications in therapeutic opportunities and precision medicine. | Genes Dis | 2022 | 35224152 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway. | Cell Death Discov | 2022 | 35210431 | PubTator, text mining | PubMed |
| The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach. | Cancers (Basel) | 2022 | 35205782 | PubTator, text mining | PubMed |
| CRL4Cdt2 Ubiquitin Ligase, A Genome Caretaker Controlled by Cdt2 Binding to PCNA and DNA. | Genes (Basel) | 2022 | 35205311 | PubTator, text mining | PubMed |
| Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 Interactors. | Antioxidants (Basel) | 2022 | 35204174 | PubTator, text mining | PubMed |
| Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma. | Nat Commun | 2022 | 35197447 | PubTator, text mining | PubMed |
| ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression. | Cell Death Differ | 2022 | 35194188 | PubTator, text mining | PubMed |
| Yeast β-glucan Increases Etoposide Sensitivity in Lung Cancer Cell Line A549 by Suppressing Nuclear Factor Erythroid 2-Related Factor 2 via the Noncanonical Nuclear Factor Kappa B Pathway. | Mol Pharmacol | 2022 | 35193967 | PubTator, text mining | PubMed |
| Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer. | BMC Cancer | 2022 | 35193569 | PubTator, text mining | PubMed |
| Global and transcription-coupled repair of 8-oxoG is initiated by nucleotide excision repair proteins. | Nat Commun | 2022 | 35190564 | PubTator, text mining | PubMed |
| Transcription factor protein interactomes reveal genetic determinants in heart disease. | Cell | 2022 | 35182466 | PubTator, text mining | PubMed |
| MicroRNA-363-3p, negatively regulated by long non-coding RNA small nucleolar RNA host gene 5, inhibits tumor progression by targeting Aurora kinase A in colorectal cancer. | Bioengineered | 2022 | 35166647 | PubTator, text mining | PubMed |
| Defective protein degradation in genetic disorders. | Biochim Biophys Acta Mol Basis Dis | 2022 | 35158019 | PubTator, text mining | PubMed |
| LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis. | J Cancer | 2022 | 35154469 | PubTator, text mining | PubMed |
| The Mechanism and Function of miRNA in Intervertebral Disc Degeneration. | Orthop Surg | 2022 | 35142050 | PubTator, text mining | PubMed |
| Non-proteolytic ubiquitylation in cellular signaling and human disease. | Commun Biol | 2022 | 35136173 | PubTator, text mining | PubMed |
| Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature. | Cancer Biol Ther | 2022 | 35129063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8451/papers?page=20